These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Safety in transfusion practice. Is it safe to eliminate the major crossmatch for selected patients? Shulman IA, Kent D. Arch Pathol Lab Med; 1989 Mar; 113(3):270-2. PubMed ID: 2919957 [Abstract] [Full Text] [Related]
6. Experience with the routine use of an abbreviated crossmatch. Shulman IA, Nelson JM, Saxena S, Thompson JC, Okamoto M, Kent DR, Nakayama RK. Am J Clin Pathol; 1984 Aug; 82(2):178-81. PubMed ID: 6465079 [Abstract] [Full Text] [Related]
7. A delayed hemolytic transfusion reaction (DHTR) with multiple alloantibodies (Anti-E, Jka, Dia, Fyb, and S) induced by E-antigen-negative, crossmatch-compatible blood. Yamane K, Yagihashi A, Sasaki M, Kuwashima K, Morio A, Watanabe N. Immunopharmacol Immunotoxicol; 1998 Nov; 20(4):531-9. PubMed ID: 9805232 [Abstract] [Full Text] [Related]
19. A prospective study to determine the safety of omitting the antiglobulin crossmatch from pretransfusion testing. Heddle NM, O'Hoski P, Singer J, McBride JA, Ali MA, Kelton JG. Br J Haematol; 1992 Aug 05; 81(4):579-84. PubMed ID: 1390245 [Abstract] [Full Text] [Related]
20. Effect of delayed centrifugation or reading on the detection of ABO incompatibility by the immediate-spin crossmatch. Shulman IA, Calderón C. Transfusion; 1991 Aug 05; 31(3):197-200. PubMed ID: 2003320 [Abstract] [Full Text] [Related] Page: [Next] [New Search]